Ethics approval and consent to participate
ICH
The protocol was approved by the National Competent Authorities in the participating countries (Sweden, Norway and Denmark) and registered in ClinicalTrials.gov (NTC02248012). The study was conducted in accordance with the Declaration of Helsinki and ICH guidelines for Good Clinical Practice. Written informed consent was obtained from all patients prior to inclusion.